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Thymidylate synthase (TS) is a critical enzyme for DNA biosynthesis and many nonclassical lipophilic 
antifolates targeting this enzyme are quite efficient and encouraging as antitumor drugs. In this paper, 
the binding model of 14 antifolates of substituted benzylamino- and heterocyclylmethylamino-     
carbodithioate derivatives of 4-(3H)-quinazolinone with TS is examined using molecular simulation 
methods――  FlexiDock and SCORE2.0. The resulting conformation and orientation of these antifolates 
are directly applied to CoMFA study. The robust QSAR model, its three-dimensional contour map, and 
binding score of these antifolates derived from SCORE2.0 provide guidelines for structural optimiza-
tion of current antifolates. The experiment indicates that deletion of cancer chemopreventive structure 
of dithiocarbamate is unfavorable for interaction between TS and antifolates. 
thymidylate synthase, antifolate, FlexiDock, QSAR, SCORE 
Thymidylate synthase (TS) catalyzes the conversion of 
dUMP to dTMP using the cofactor CH2THF, providing 
the sole de novo means for synthesizing dTMP. TMP is 
required for DNA synthesis and inhibition of TS has 
proven to be an effective target for anticancer drug de-
sign[1]. Structural modification of folic acid led to the 
discovery of a number of antifolates as efficient anti-
cancer agents, for example, Raltitrexed (ZD1694, 
D16414), an antifolate, has been registered widely for 
the first-line treatment of advanced colorectal cancer[1―8]. 
However, these classical antifolates containing L-glu-    
tamic acid moiety in molecule have shortcomings such 
as drug resistance and liver toxicity[2,3]. One strategy to 
overcome these shortcomings is to design nonclassical 
lipophilic inhibitors of folate requiring enzymes by de-
leting or modifying L-glutamic acid component from the 
folate analogues[9]. Cao et al.[9―11] incorporated the can-
cer chemopreventive structure of dithiocarbamate moi-
ety into 4-(3H)-quinazolinone, synthesized several series 
of compounds and found their in vitro antitumor activity. 
In this paper, the binding model of 14 antifolates of sub-
stituted benzylamino- and heterocyclylmethylamino-   
carbodithioate derivatives of 4-(3H)-quinazolinone syn-
thesized by Cao et al. is examined using molecular 
simulation methods――  Flexi-Dock and SCORE2.0, then 
to quantitatively disclose the relationship between activ-
ity and structure, we developed a 3D-QSAR model 
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with these aligned antifolates using CoMFA. The final 
results provided some guidelines for structural optimiza-
tion of current antifolates. 
1  Materials and methods 
1.1  Materials 
A series of 14 substituted benzylamino- and heterocy-
clylmethylamino-carbodithioate derivatives of 4-(3H)-    
quinazolinone used in this study are listed in Table 1. 
Eleven of these compounds were selected as the training 
set, the rest labeled with “a)” as the test set for the vali-
dation of the final model. The biological activity of each 
compound expressed as IC50, which is the inhibitory 
concentration of compounds needed to inhibit 50% of 
K562 proliferation, was converted to pIC50 (−lgIC50) for 
the 3D-QSAR analysis. The inhibitory activities shown 
as IC50 values were tested through the MTT[12]. 
1.2  Molecular docking and alignment 
Three-dimensional structure building and all modeling 
were performed using the Sybyl7.1 (Created Jun 17, 
2005) program package. The crystal structure of the com-
plex of human TS with D16414 (ZD1694, Tomudex) was  
recovered from the Brookhaven Protein Data Bank 
(http://www.rcsb.org/pdb/) (entry code 1HVY)[13]. The 
potential of the 3D structure of TS was assigned ac-
cording to the Tripos Force Field[14] with Kollman-    
all-atom[15] charges in Sybyl7.1. The antifolates were 
built in the sketch molecule package. Each structure was 
fully geometry optimized using Powell method in Tripos 
force field with a distance-dependent dielectric function 
and a 0.005 kcal/(mol·Å) energy gradient convergence 
criterion. Partial atomic charges were calculated using 
Gasteiger-Hückel method[16]. 
CoMFA results may be extremely sensitive to a 
number of factors, such as alignment rules, overall ori-
entation of aligned compounds, lattice shifting, step size 
and the probe atom type[17]. The selection of bioactive 
conformer and ascertainment of alignment rule are the 
most critical factors to 3D-QSAR. In principle, the 
actual bioactive conformation and the best alignment 
can only be derived from the complex structure of ligand 
and receptor. So we performed a docking-guided con-
formation selection by FlexiDock[18,19] in Sybyl7.1. The 
Lamarckian genetic algorithm (LGA)[20] was applied to 
dealing with the inhibitor-enzyme interactions. Replac- 
 
Table 1  The structures of antifolates and their PIC50 




































a) These compounds were in the test set. 
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ing the D16414 with these antifolates one by one into 
the complex structure 1HVY, structurally optimized 
receptor, the initial conformations of these antifolates 
were docked into the binding site among the 
3D-structural models of TS. Then the docked ligands 
were subjected to flexible docking calculation employ-
ing FlexiDock in Sybyl7.1. All the single bonds of 
ligand and the side chains of the amino acid residues 
around the ligand, as well as the orientation of the ligand 
were taken as variables within the interaction region for 
flexible docking calculation. Then, we obtained the ini-
tial structures of the ligand-receotor complexes, which 
were successively refined using minimization. The 
binding energy (Ebind) of the ligand was calculated using 
the following formula: 
Ebind = Ecomplex−Eligand−Ereceptor;        (1) 
where Eligand is the energy of the ligand corresponding to 
the lower energy conformation and Ereceptor is the energy 
of the receptor. 
The conformer with the lowest binding energy was 
extracted from the docking result file and used for 
alignment. Aligned molecular aggregates were obtained 
by the Sybyl7.1 routine “Align Database”. TMA was 
chosen as the template and the rest of training set mole-
cules were aligned to it by the common substructure 
labeled with * in Figure 1 for the CoMFA[21] study.  
 
Figure 1  Template molecule TMA. 
1.3  CoMFA and 3D-QSAR model 
For the CoMFA calculation, the aligned molecules were 
placed one by one into a 3D cubic lattice with a 2Å 
spacing. The default sp3 carbon atom with +1 charge 
was selected as the probe atom for the calculations of 
the steric (Lennard-Jones 6―12 potential) and electro-
static fields (Coulombic potential) around the aligned 
molecules with a distance-dependent dielectric constant 
at each lattice point. A 30 kcal/mol energy cutoff was 
applied, which means steric and electrostatic energy 
greater than 30 kcal/mol was truncated to that value. 
Steric and electrostatic fields generated were scaled by 
the CoMFA-STD method in Sybyl7.1. The correlation 
of the CoMFA descriptor with corresponding pIC50 was 
evaluated by the PLS regression analysis module[22―24] 
in Sybyl7.1. To avoid overfitted 3D-QSAR, the opti-
mum number of components (N) to be used in the model 
derivation was chosen from the analysis with the highest 
cross-validated correlation coefficient (q2). The cross-     
validated q2 quantifies the predictive ability of the model 
and is determined by a leave-one-out (LOO) procedure 
of cross-validation in which each compound is succes-
sively removed from the model derivation and its pIC50 
value can be predicted using the model built from the 
remaining compounds. The optimum number of com-
ponents was determined in such a way that each addi-
tional component should increase the q2 by at least 
5%[25]. In order to speed up the analysis and reduce 
noise, the column filtering was set to 1.0 kcal/mol, so 
that only those steric and electrostatic energy with val-
ues greater than 1.0 kcal/mol was considered in the PLS 
analysis. The CoMFA descriptors were used as inde-
pendent variables, and the pIC50 values were used as 
dependent variables in PLS regression analyses to derive 
the 3D-QSAR model using the standard implementation 
in the Sybyl7.1. The predictive value of model was 
evaluated first by leave-one-out cross-validation. The 
cross-validation coefficient, q2, was calculated by using 
relative equation[26]. Cho et al.[17] reported that q2 value 
was sensitive to the orientation of aligned molecules on 
the computer terminal and might vary with the orienta-
tion by as much as 0.5 q2 units. So in our CoMFA 
analysis, all-orientation and all-placement searching was 
performed by rotating the molecular aggregate system-
atically every 30° along the X, Y, and Z axes and trans-
lating it every 0.2 Å, at every place, the cross-validated 
q2 of PLS calculated, until obtaining a maximal q2 value. 
In this paper, the maximal q2 is obtained by translating 
aligned molecules 1 Å along the horizontal axis at two 
directions respectively at 2 Å step size and 1 kcal/mol 
column filtering. 
1.4  Score 
The 3D-structure of antifolates extracted from ligand- 
receptor complexes after FlexiDock was scored using 
SCORE2.0[27―29]. 
pKd = 2.254+(0.916)MB−(0.168)VB+(0.141)WHB 
+(0.216)MHB+(0.593)SHB +(0.327)WWH 
−(0.708)MWH+(0.291)SWH+(1.178)HM 
−(0.169)RT.            (2) 
MB, coordinate bonding with metal ion; VB, VDW 
bump; WHB, weak H-bond; MHB, moderate H-bond; 
SHB, strong H-bond; WWH, weak water H-bond; 
MWH, moderate water H-bond; SWH, strong water 
 


























H-bond; HM, hydrophobic matching; RT, rotatable sin-
gle bond. 
2  Results and discussion 
2.1  Molecular docking 
The initial conformation of these antifolates was em-
ployed to perform flexible docking calculation by the 
FlexiDock program in Sybyl7.1. Twenty solutions for 
each antifolate were obtained after calculation and the 
complex structure with the lowest energy was chosen for 
study. The conformation and orientation of each anti-
folate were extracted from the complex structure for 
further research. The binding mode of substituted ben-
zylamino- and heterocyclylmethylamino- carbodithioate 
derivatives of 4-(3H)-quinazolinone with TS could be 
explained explicitly with the 3D structures of these an-
tifolate-TS complexes. In the 3D structure of docked 
complex, the quinazolinone and the lipophilic moieties 
of the 14 antifolates were in the hydrophobic groove 
formed by hydrophobic residues of TS, such as Phe80, 
Val79, Phe225, Gly83, Val84, Leu221, Asn226, Ile108, 
Met311, Pro224, Val313, His196, Gly222, Trp109 and 
Leu192. Hydrogen bonding (Table 2) was the important 
intermolecular interaction.  
 
Table 2  Hydrogen bonding between these antifolates and TS 





Asp218 CO 2FB N(3) 2.408 131.2 
ADM O(1) Asn112 -NH2 1.473 163.98 
Leu221 CO TMA NH(16) 2.210 160.36 
Asp218 CO QPM NH(3) 1.787 143.82 
 
For example, the distance between the H of NH(16) 
of TMA and CO of the residue Leu221 side chain was 
2.210 Å, shown with a dash line in red (Figure 2).   
Table 3 lists the binding energy data of the 14 anti-
folate-TS complexes. A classical QSAR was performed 
to explore whether the inhibitory activities of these an-
tifolates could be correlated with the binding energy. 
Employing the PLS method in Sybyl7.1, we calculated 
the regression equation for the inhibitory activities 
(pIC50), using the binding energy Ebind as the sole de-
scriptor variable. A good correlation was found between 
the inhibitory activities and binding energy. 
pIC50 = −1.580+0.002 Ebind,         (3) 
which is an indirect proof for the reasonability of the 3D 
structures of antifolate-TS complexes predicted by our 
modeling method. 
 
Table 3  Binding energy of 14 antifolate-TS complexes 
Compound pIC50 ΔE (kcal/mol) Compound pIC50 ΔE (kcal/mol)
2FB −2.59 −481.44 AMB −2.40 −532.25 
4CB −2.58 −486.19 QAT −2.08 −407.71 
4FB −2.56 −474.10 QMT −2.26 −367.52 
4MB −2.61 −480.26 QPF −2.63 −474.65 
ADM −2.20 −467.32 QPM −2.56 −464.78 
DMB −2.35 −365.77 TFA −2.30 −468.55 
OMA −2.55 −448.94 TMA −2.43 −436.95 
 
2.2  3D-QSAR model and CoMFA analysis 
Eleven of 14 antifolates constitute the training set, the 
rest labeled with “a” the test set. The aligned molecular 
aggregates are shown in Figure 3. A QSAR model was 
obtained using the methods of docking-guided con-
former selection and all orientation and all-placment 
searches. The PLS statistics of the CoMFA analyses are 
summarized in Table 4. The cross-validated q2 value 
was 0.534 with 6 components and noncross-validated 
conventional r2 value was 0.999 with a standard error of 
estimate (SEE) value of 0.007. The relative contribution 
between steric and electrostatic fields for CoMFA model 
was 0.669 and 0.331 respectively. 
 





2 S F 
0.534 6 0.999 0.007 1367.666
 
The contours of the steric and electrostatic fields were 
displayed. The steric contours (Figure 4) are displayed 
in yellow and green and the electrostatic contours (Fig-
ure 5) in red and blue. 
Introduction of either the electron-donating groups  
(—OCH3) or the electron-withdrawing groups (—F, —Cl 
and —COOH) at the 4′-position of the phenyl ring did 
not cause the increase in bioactivity compared with the 
parent compound BZA[9], whose pIC50 was 2.40. Re-
placement of the phenyl group in compound BZA by 
2-thiophenyl, and 2-tetrahydrofuryl, resulting in com-
pounds TMA and TFA, also leads to the decrease in ac-
tivity. 
2.3  Validation of the QSAR model 
To test the stability and predictive ability of the 
3D-QSAR model, 3 antifolates, which were not included 
in the CoMFA model, were selected as a set for valida- 
tion. The residual between experimental and pre-
dicted pIC50 for this test set is listed in Table 5. The cor- 
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Figure 2  3D structure of the TMA complex with TS and the binding score of TMA. (a) TMA complex with TS (one hydrogen bond shown with a dash 














Figure 3  The aligned molecular aggregates. 
 
      
Figure 4  The steric field contours of the QSAR model. The yellow 
contours indicate regions of negative steric potential, while the green 
contours the regions of positive steric potential. 
Figure 5  The electrostatic field contours of the QSAR model. The red 
contours indicate regions of negative electrostatic potential and the blue 
contours the regions of positive electrostatic potential. 
 
Table 5  Residuals of the predicted pIC50 in the test by the CoMFA 
model 
Compound Actual Predicted Residual 
4MB −2.61 −2.598 −0.012 
AMB −2.4 −2.39 −0.01 
QPF −2.63 −2.626 −0.004 
 
relation between experimental and predicted pIC50 for 
training set is shown in Figure 6. It was shown that the 
model was stable and had robust predictive ability. 
2.4  Score 
Performing scoring for every antifolate within the 
docked complex, we obtained a score for every atom of 
every antifolate and assessed the contribution of every 
atom to the interaction between antifolates and TS (Ta-
 


























ble 6). The atoms, with score above 0.1, were favorable 
for the interaction, and those with score below −0.1 were 
unfavorable. The common favorable atoms of these 14 
antifolates were phenyl moiety of quinazolinone and the 
phenyl moiety connected with the —CH2. The common 
unfavorable atoms of these 14 antifolates were —CH2 
or —NH connected with the phenyl moiety. 
 
Figure 6  Predicted versus experimental inhibitory activities for training 
set. 
 
Table 6  Binding score of TMA 
No. Type Score No. Type Score No. Type Score
1 O.2 0.000 9 C.ar 0.343 17 S.2 −0.336
2 C.3 0.557 10 C.ar 0.258 18 C.3 −0.169
3 N.2 0.000 11 C.ar 0.343 19 C.ar 0.258
4 C.3 0.268 12 C.ar 0.343 20 C.ar 0.343
5 N.3 0.000 13 C.ar 0.343 21 C.ar 0.000
6 C.2 0.000 14 S.3 0.439 22 C.ar 0.000
7 C.2 0.000 15 C.2 −0.169 23 S.2 0.000
8 C.ar 0.343 16 N.3 −0.028    
No., atom number; Type, atom type; Score, binding score. 
 
The subscript number represents atom number. 
3  Conclusion 
We applied FlexiDock, CoMFA, and SCORE2.0 to re-
search the binding mode of a set of antifolates to TS 
receptor. After flexible docking, the hydrogen bonds 
between antifolates and the residues of TS were discov-
ered. FlexiDock results indicated that the binding energy 
of the antifolates correlates well with the experimental 
inhibitory activities against TS, and the modeling results 
provided satisfactory explanation for the binding mode 
of these antifolates with TS. The probable conforma-
tions were selected by the docking-guided conformer 
selection method, and the 3D-QSAR model was obtained 
by the method of all-orientation and all-placement, whose 
statistical parameter (PLS) was ideal. Comparing to the 
compounds of FUR, DET, MOR, PDQ, etc.[9], the bioac-
tivities of these antifolates of ADM, TMA, TFA, 4MB, 
DMB, 4FB, 2FB, 4CB, and AMB in this paper with   
—CH2 connected to the phenyl were much low. The 
scores of —CH2 of those compounds mentioned above 
in this study were all below −0.1 using SCORE2.0, so 
introduction of —CH2 into these compounds was unfa-
vorable. The bioactivities of another 5 antifolates of QAT, 
QMT, OMA, QPM, and QPF deletion of dithiocarbamate 
were also much low, the scores of —N which connect 
with the phenyl moiety were all below −0.1, so deletion 
of cancer chemopreventive structure of dithiocarbamate 
was unfavorable.  
Based on the result of 3D-QSAR, the relative contri-
bution between steric and electrostatic fields for the 
CoMFA model was 0.669 and 0.331 respectively, so 
steric field played dominant role in antifolate-TS inter-
action. In this study, we combined the results of 
3D-QSAR with SCORE2.0, which leads to a better un-
derstanding of important antifolate-TS interactions and 
thus provided guidelines for ligand design plus a predic-
tive model for scoring novel synthetic candidates. 
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